Loading events...
This transcript covers Altimmune's presentation at the Jefferies Conference, focusing on their strategic insights regarding pemvidutide. Pemvidutide is likely a pharmaceutical product or drug candidate being developed by Altimmune, and the conference presentation likely provided updates on its development, clinical trials, or market potential.
This transcript covers Altimmune's presentation at the Jefferies Conference, focusing on their strategic insights regarding pemvidutide. Pemvidutide is likely a pharmaceutical product or drug candidate being developed by Altimmune, and the conference presentation likely provided updates on its development, clinical trials, or market potential.
Receive curated event recommendations based on your interests.
See how WebMobi helps you manage registration, check-in, and analytics.
Request a DemoOr start free trial →Date to be announced. Check the event website for updates.
Location to be announced. Check the event website for updates.
Pricing information is available on the event website.
Altimmune at Jefferies Conference: Strategic Insights on Pemvidutide is designed for finance professionals looking to network, learn, and discover new opportunities.
Get curated B2B events, AI-powered insights, and industry trends delivered to your inbox